HeartSciences Inc. (HSCS) EPS (Basic) (2021 - 2026)

HeartSciences (HSCS) has reported EPS (Basic) for 6 consecutive years, with -$1.05 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EPS (Basic) rose 52.98% year-over-year to -$1.05; the trailing twelve-month figure through Apr 2026 stood at -$3.53 (up 62.55% YoY), and the FY2026 full-year result was -$3.49, up 63.0% from the prior year.
• EPS (Basic) retreated to -$1.05 in Q2 2026 per HSCS's latest filing, from -$0.85 in the prior quarter.
• Across five years, EPS (Basic) topped out at -$0.13 in Q3 2023 and bottomed at -$5.39 in Q2 2024.
• Historically, EPS (Basic) has averaged -$1.4 across 5 years, with a median of -$0.85 in 2025.
• The sharpest annual moves came in 2023 and 2024: EPS (Basic) soared 66.83% in 2023, then plunged 2525.72% in 2024.
• Over 5 years, EPS (Basic) stood at -$0.22 in 2022, then climbed by 27.41% to -$0.16 in 2023, then plunged by 1333.91% to -$2.29 in 2024, then surged by 63.08% to -$0.85 in 2025, then retreated by 24.44% to -$1.05 in 2026.
• According to Business Quant data, EPS (Basic) over the past three periods registered -$1.05, -$0.85, and -$1.58 for Q2 2026, Q4 2025, and Q3 2025 respectively.